相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals
Qi Pan et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Needle-free jet injection of insulin glargine improves glycemic control in patients with type 2 diabetes mellitus: a study based on the flash glucose monitoring system
Xiaocen Kong et al.
EXPERT OPINION ON DRUG DELIVERY (2021)
Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT
Jin J. Zhou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Profiles of Intraday Glucose in Type 2 Diabetes and Their Association with Complications: An Analysis of Continuous Glucose Monitoring Data
Jithin Sam Varghese et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naive Chinese Type 2 Diabetes Patients
James Ling et al.
DIABETES THERAPY (2021)
Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial
Lu Yuan et al.
JOURNAL OF DIABETES RESEARCH (2021)
Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
Chun-Pai Yang et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study
Yi-Ting Hsieh et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)
Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study
Yuri D. Foreman et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Comparison of glucose variability in patients with type 2 diabetes administrated glargine with needle-free jet injector and conventional insulin pen
Yixuan Sun et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trial
Wenying Yang et al.
DIABETES OBESITY & METABOLISM (2019)
Efficacy and safety of a needle-free injector in Chinese patients with type 2 diabetes mellitus treated with basal insulin: a multicentre, prospective, randomised, crossover study
Ying Xing et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials
J. Hans DeVries et al.
DIABETES OBESITY & METABOLISM (2019)
Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report
Daisuke Matsutani et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Trajectories of fasting plasma glucose variability and mortality in type 2 diabetes
Chia-Lin Lee et al.
DIABETES & METABOLISM (2018)
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
Bernard Zinman et al.
DIABETOLOGIA (2018)
The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
Ji Eun Jun et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial
Yoichiro Hirakawa et al.
DIABETES CARE (2014)
Needle-Free Jet Injection of Rapid-Acting Insulin Improves Early Postprandial Glucose Control in Patients With Diabetes
Elsemiek E. C. Engwerda et al.
DIABETES CARE (2013)
Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology
Elsemiek E. C. Engwerda et al.
DIABETES CARE (2011)
Comparison of fasting capillary glucose variability between insulin glargine and NPH
Panwei Mu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Pharmacokinetics and Pharmacodynamics of Basal Insulins
Francesca Porcellati et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Randomized Trial on the Influence of the Length of Two Insulin Pen Needles on Glycemic Control and Patient Preference in Obese Patients with Diabetes
Gillian Kreugel et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Comparative glycemic control, safety and patient ratings for a new 4mm x 32G insulin pen needle in adults with diabetes
Laurence J. Hirsch et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Defining the Ideal Injection Techniques When Using 5-mm Needles in Children and Adults
Paul Leslie Hofman et al.
DIABETES CARE (2010)
Insulin Leakage Value in Relation to Pen Needle Length and Administered Dose After Subcutaneous Injection
Andreas Wittmann et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2010)
Comparison of Usability and Patient Preference for Insulin Pen Needles Produced with Different Production Techniques: Thin-Wall'' Needles Compared to Regular-Wall'' Needles: An Open-Label Study
Thorsten Siegmund et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan
I. Salti
DIABETIC MEDICINE (2009)
Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
HE Scholtz et al.
DIABETOLOGIA (2005)
Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
T Heise et al.
DIABETES (2004)
Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients - The Verona Diabetes Study
M Muggeo et al.
DIABETES CARE (2000)
分享论文
